Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2017

Aug 24, 2017

35221_dirs_2017-08-24_0c79eeaa-c614-4b96-b047-b93d7d26c79e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2017-08-23

Reporting Person: MCGRATH DENNIS M (EVP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-23 Common Stock P 500 $3.904 Acquired 6500 Indirect
2017-08-23 Common Stock P 500 $4.1184 Acquired 7000 Indirect
2017-08-23 Common Stock P 500 $4.1234 Acquired 7500 Indirect
2017-08-23 Common Stock P 500 $4.1496 Acquired 8000 Indirect
2017-08-23 Common Stock P 500 $4.17 Acquired 8500 Indirect
2017-08-23 Common Stock P 500 $4.1788 Acquired 9000 Indirect